دورية أكاديمية

Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer

التفاصيل البيبلوغرافية
العنوان: Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancer
المؤلفون: Kunder, Ratika, Velyunskiy, Michelle, Dunne, Sara F., Cho, Byoung-Kyu, Kanojia, Deepak, Begg, Lauren, Orriols, Adrienne M., Fleming-Trujillo, Erica, Vadlamani, Pranathi, Vialichka, Alesia, Bolin, Rosemary, Perrino, Jessica N., Roth, Diane, Clutter, Matthew R., Zielinski-Mozny, Nicolette A., Goo, Young Ah, Cristofanilli, Massimo, Mendillo, Marc L., Vassilopoulos, Athanassios, Horiuchi, Dai
المصدر: Cell Chemical Biology ; volume 29, issue 3, page 358-372.e5 ; ISSN 2451-9456
بيانات النشر: Elsevier BV
سنة النشر: 2022
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Clinical Biochemistry, Drug Discovery, Pharmacology, Molecular Biology, Molecular Medicine, Biochemistry
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.chembiol.2021.08.011
الإتاحة: https://doi.org/10.1016/j.chembiol.2021.08.011Test
https://api.elsevier.com/content/article/PII:S2451945621004001?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2451945621004001?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://www.elsevier.com/open-access/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test
رقم الانضمام: edsbas.A8E1F2CF
قاعدة البيانات: BASE